Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors
Compose a Response to This Article
Other responses
No responses have been published for this article.
